论文部分内容阅读
作者检测变态反应性荨麻疹和非变态反应性荨麻疹患者血浆中中分子(middle molecular substances MMS)含量。结果变态反应性荨麻疹患者血浆中MMS含量与健康对照组和非变态反应性荨麻疹组比较差别有高度显著性。所以MMS测定可作为临床对变态反应性荨麻疹和非变态反应性荨麻疹鉴别的辅助诊断之一
The authors examined the plasma concentrations of middle molecular substances (MMS) in patients with allergic urticaria and non-allergic urticaria. Results There was a significant difference in the levels of MMS in the plasma of patients with allergic urticaria compared with healthy controls and non-allergic urticaria patients. Therefore, MMS can be used as a clinical diagnosis of allergic urticaria and non-allergic urticaria